| Mrs Daisy Kwok, RPH | |
|
951 N Harbor Blvd, La Habra, CA 90631-3103 | |
| (562) 697-4718 | |
| (562) 697-4858 |
| Full Name | Mrs Daisy Kwok |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 951 N Harbor Blvd, La Habra, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164741344 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 29359 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Daisy Kwok, RPH 951 N Harbor Blvd, La Habra, CA 90631-3103 Ph: (562) 697-4718 | Mrs Daisy Kwok, RPH 951 N Harbor Blvd, La Habra, CA 90631-3103 Ph: (562) 697-4718 |
News Archive
The Medical Research Council (MRC) is to fund a research proposal from a team at the North East England Stem Cell Institute (NESCI) for a project to find ways of improving the efficiency of therapeutic cloning - a technique which would allow scientists to create patient-specific stem cells and develop regenerative therapies for many debilitating conditions such as diabetes, heart disease and Parkinson's disease.
The idea is to use a modified form of HIV to deliver an "antisense" gene to the immune cells that HIV infects. This is integrated into the cells' genome, and stays there until a cell is infected. Then it is switched on, and produces RNA complementary to the "sense" RNA encoding a viral protein. In theory, the RNAs should bind together, blocking viral replication.
H. Lundbeck A/S (Lundbeck) and Merck, known outside the United States and Canada as MSD, today announced a commercialization agreement for SYCREST (asenapine) sublingual tablets (5 mg, 10 mg). Under the terms of the agreement, Lundbeck will pay an undisclosed fee as well as product supply payments in exchange for exclusive commercial rights to SYCREST in all markets outside the United States, China and Japan. Lundbeck expects to launch SYCREST in the European Union (EU), where it is already approved, at the beginning of 2011.
Microlife Medical Home Solutions, Inc. (MiMHS) announces The Biggest Loser medical staff will implement the MedGem indirect calorimeter to assess metabolic changes in program contestants. The MedGem handheld indirect calorimeter is an FDA-cleared, Class II, medical device that assesses metabolic rate by measuring a patient's resting oxygen consumption.
› Verified 1 days ago
Quang Vu, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1000 E Imperial Hwy, Walmart Pharmacy Manager, La Habra, CA 90631 Phone: 714-869-0539 Fax: 714-869-0531 | |
Krishna Sanjay Patel, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2000 W Whittier Blvd, La Habra, CA 90631 Phone: 562-690-5567 | |
Indravadan Rambhai Patel, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 340 N Harbor Blvd, La Habra, CA 90631 Phone: 562-691-0539 | |
Nguyet-minh Nguyen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1340 S Beach Blvd, La Habra, CA 90631 Phone: 562-694-4587 Fax: 562-694-4328 | |
Jenny Zamora, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1340 S Beach Blvd, La Habra, CA 90631 Phone: 562-694-4587 | |
Cindy Oh, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1390 S Beach Blvd, La Habra, CA 90631 Phone: 562-697-9324 | |
Dr. Brian K Vo, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1700 W Whittier Blvd, La Habra, CA 90631 Phone: 562-694-4367 |